INS and diabetes mellitus: Systemic corticosteroids, such as prednisone and methylprednisolone, are associated with significant metabolic effects, including increased hepatic glucose production, reduced insulin sensitivity, and enhanced lipolysis, all of which contribute to worsening hyperglycemia and increased risk of diabetes onset or progression [86].